ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002